---
title: "禮來公司暫停了與 Zepbound 合作的肌肉保護藥物的糖尿病試驗 - 彭博社報道"
description: "9 月 25 日（路透社）- 禮來暫停了與 Zepbound 聯合進行的肌肉保護藥物糖尿病試驗 - 彭博新聞"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/258857485.md"
published_at: "2025-09-25T10:40:35.000Z"
---

# 禮來公司暫停了與 Zepbound 合作的肌肉保護藥物的糖尿病試驗 - 彭博社報道

> 9 月 25 日（路透社）- 禮來暫停了與 Zepbound 聯合進行的肌肉保護藥物糖尿病試驗 - 彭博新聞

Sept 25 (Reuters) -

-   Eli Lilly halts diabetes trial of muscle-sparing drug with Zepbound - Bloomberg news

### Related Stocks

- [LLY.US - 禮來](https://longbridge.com/zh-HK/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026 | Eli Lilly's stock is surging due to AI deals and a favorable drug pricing agreement. The healthcare sector, particularly | [Link](https://longbridge.com/zh-HK/news/267579204.md) |
| Eli Lilly joins a very exclusive club | Eli Lilly becomes the eleventh company to surpass $1 trillion in market capitalization, marking a milestone for healthca | [Link](https://longbridge.com/zh-HK/news/267672421.md) |
| Short Interest in Schneider Electric SE (OTCMKTS:SBGSY) Drops By 16.8% | Schneider Electric SE (OTCMKTS:SBGSY) experienced a 16.8% decrease in short interest in January, with 197,858 shares sho | [Link](https://longbridge.com/zh-HK/news/276071356.md) |
| Volkswagen Mulls 20% Company-wide Cost Reduction by 2028-End | Volkswagen Mulls 20% Company-wide Cost Reduction by 2028-End | [Link](https://longbridge.com/zh-HK/news/276044410.md) |
| What to Expect from Palo Alto Networks's Earnings | Palo Alto Networks (NASDAQ:PANW) is set to release its quarterly earnings report on February 17, 2026, with analysts exp | [Link](https://longbridge.com/zh-HK/news/276061399.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。